Statera BioPharma Inc (STAB)
0.0007
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Statera BioPharma Cash and Short Term Investments (Quarterly): 0.5061M for Sept. 30, 2022
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2022 | 0.5061M |
| June 30, 2022 | 0.7169M |
| March 31, 2022 | 0.3306M |
| December 31, 2021 | 1.979M |
| Date | Value |
|---|---|
| September 30, 2021 | 9.45M |
| June 30, 2021 | 1.330M |
| March 31, 2021 | 0.1519M |
| December 31, 2020 | 0.5939M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
0.1519M
Minimum
Mar 2021
9.45M
Maximum
Sep 2021
1.882M
Average
0.6554M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Humanigen Inc | 3.096M |
| Cantabio Pharmaceuticals Inc | 0.2834M |
| Affymax Inc | -- |
| RVL Pharmaceuticals PLC | 19.16M |
| Scopus BioPharma Inc | 0.3621M |